Second application pending for under-fives COVID vaccine Pfizer has been told it can apply for its Comirnaty vaccine to be used to immunise children under five in Australia.
Australian-first study reveals boosters’ efficacy against Omicron People who received three doses of COVID-19 vaccine had 65% greater protection against hospitalisation or death than those who only had two.
‘Hybrid immunity’ enough to protect healthcare workers: DoH New advice indicates there is not enough evidence to support offering healthcare workers a fourth ‘winter dose’.
‘Large potential burden’: Long COVID warning for GPs The number of patients with lingering symptoms will almost certainly rise, with one expert calling it a ‘very significant’ public health challenge.
Diagnosis delays lead to PCR test push Vulnerable patients with symptoms should get the more sensitive test to allow treatment to be fast-tracked, says deputy CMO.
Text reminders mooted for at-risk COVID-19 patients The Federal Health Minister has asked department officials for advice on ways of further raising awareness of oral antiviral treatments.
Multiple rapid antigen test sponsors under investigation The revelation comes alongside TGA confirmation that a company has been fined more than $100,000 for ‘serial non-compliance’.
Government launches flu and COVID vaccine campaign At-risk patients have also been encouraged to talk to GPs about oral antiviral treatments if they are infected with COVID-19.
Research suggests women are more susceptible to long COVID The new findings indicate women may be more likely to develop the condition, highlighting a need to include gender as a variable.
Call on COVID vaccine for under-fives likely ‘in coming weeks’ With mRNA vaccines for children aged under-five now approved in US, authorities are actively considering a similar move in Australia.